Angiotensin II receptor blockade: physiological and clinical implications:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boston
Kluwer
1998
|
| Schriftenreihe: | Progress in experimental cardiology
2 |
| Schlagworte: | |
| Beschreibung: | XLII, 588 S. Ill., graph. Darst. |
| ISBN: | 0792381475 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012403350 | ||
| 003 | DE-604 | ||
| 005 | 20050110 | ||
| 007 | t | ||
| 008 | 990211s1998 ad|| |||| 00||| engod | ||
| 020 | |a 0792381475 |9 0-7923-8147-5 | ||
| 035 | |a (OCoLC)38562388 | ||
| 035 | |a (DE-599)BVBBV012403350 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 050 | 0 | |a RC684.A53 | |
| 082 | 0 | |a 616.1/2061 |2 21 | |
| 245 | 1 | 0 | |a Angiotensin II receptor blockade: physiological and clinical implications |c ed. by Naranjan S. Dhalla ... |
| 264 | 1 | |a Boston |b Kluwer |c 1998 | |
| 300 | |a XLII, 588 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Progress in experimental cardiology |v 2 | |
| 650 | 4 | |a Angiotensin II |x physiology |v Congresses | |
| 650 | 4 | |a Angiotensin converting enzyme |x Inhibitors |v Congresses | |
| 650 | 4 | |a Angiotensins |v Congresses | |
| 650 | 4 | |a Heart Diseases |x drug therapy |v Congresses | |
| 650 | 4 | |a Hypertension |x drug therapy |v Congresses | |
| 650 | 4 | |a Receptors, Angiotensin |x antagonists & inhibitors |v Congresses | |
| 650 | 4 | |a Renin-Angiotensin System |x physiology |v Congresses | |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Angiotensin-II-Blocker |0 (DE-588)4368837-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1996 |z Winnipeg Manitoba |2 gnd-content | |
| 689 | 0 | 0 | |a Angiotensin-II-Blocker |0 (DE-588)4368837-8 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Dhalla, Naranjan S. |d 1936- |e Sonstige |0 (DE-588)104116595 |4 oth | |
| 830 | 0 | |a Progress in experimental cardiology |v 2 |w (DE-604)BV012373475 |9 2 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008414051 | ||
Datensatz im Suchindex
| _version_ | 1804127037136306176 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)104116595 |
| building | Verbundindex |
| bvnumber | BV012403350 |
| callnumber-first | R - Medicine |
| callnumber-label | RC684 |
| callnumber-raw | RC684.A53 |
| callnumber-search | RC684.A53 |
| callnumber-sort | RC 3684 A53 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)38562388 (DE-599)BVBBV012403350 |
| dewey-full | 616.1/2061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/2061 |
| dewey-search | 616.1/2061 |
| dewey-sort | 3616.1 42061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01760nam a2200457 cb4500</leader><controlfield tag="001">BV012403350</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050110 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">990211s1998 ad|| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0792381475</subfield><subfield code="9">0-7923-8147-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)38562388</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012403350</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC684.A53</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/2061</subfield><subfield code="2">21</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Angiotensin II receptor blockade: physiological and clinical implications</subfield><subfield code="c">ed. by Naranjan S. Dhalla ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston</subfield><subfield code="b">Kluwer</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XLII, 588 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Progress in experimental cardiology</subfield><subfield code="v">2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Angiotensin II</subfield><subfield code="x">physiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Angiotensin converting enzyme</subfield><subfield code="x">Inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Angiotensins</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart Diseases</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Receptors, Angiotensin</subfield><subfield code="x">antagonists & inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Renin-Angiotensin System</subfield><subfield code="x">physiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Angiotensin-II-Blocker</subfield><subfield code="0">(DE-588)4368837-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1996</subfield><subfield code="z">Winnipeg Manitoba</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Angiotensin-II-Blocker</subfield><subfield code="0">(DE-588)4368837-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dhalla, Naranjan S.</subfield><subfield code="d">1936-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)104116595</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Progress in experimental cardiology</subfield><subfield code="v">2</subfield><subfield code="w">(DE-604)BV012373475</subfield><subfield code="9">2</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008414051</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1996 Winnipeg Manitoba gnd-content |
| genre_facet | Konferenzschrift 1996 Winnipeg Manitoba |
| id | DE-604.BV012403350 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:26:58Z |
| institution | BVB |
| isbn | 0792381475 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008414051 |
| oclc_num | 38562388 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XLII, 588 S. Ill., graph. Darst. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Kluwer |
| record_format | marc |
| series | Progress in experimental cardiology |
| series2 | Progress in experimental cardiology |
| spelling | Angiotensin II receptor blockade: physiological and clinical implications ed. by Naranjan S. Dhalla ... Boston Kluwer 1998 XLII, 588 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Progress in experimental cardiology 2 Angiotensin II physiology Congresses Angiotensin converting enzyme Inhibitors Congresses Angiotensins Congresses Heart Diseases drug therapy Congresses Hypertension drug therapy Congresses Receptors, Angiotensin antagonists & inhibitors Congresses Renin-Angiotensin System physiology Congresses Pharmakologie (DE-588)4045687-0 gnd rswk-swf Angiotensin-II-Blocker (DE-588)4368837-8 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1996 Winnipeg Manitoba gnd-content Angiotensin-II-Blocker (DE-588)4368837-8 s Pharmakologie (DE-588)4045687-0 s DE-604 Dhalla, Naranjan S. 1936- Sonstige (DE-588)104116595 oth Progress in experimental cardiology 2 (DE-604)BV012373475 2 |
| spellingShingle | Angiotensin II receptor blockade: physiological and clinical implications Progress in experimental cardiology Angiotensin II physiology Congresses Angiotensin converting enzyme Inhibitors Congresses Angiotensins Congresses Heart Diseases drug therapy Congresses Hypertension drug therapy Congresses Receptors, Angiotensin antagonists & inhibitors Congresses Renin-Angiotensin System physiology Congresses Pharmakologie (DE-588)4045687-0 gnd Angiotensin-II-Blocker (DE-588)4368837-8 gnd |
| subject_GND | (DE-588)4045687-0 (DE-588)4368837-8 (DE-588)1071861417 |
| title | Angiotensin II receptor blockade: physiological and clinical implications |
| title_auth | Angiotensin II receptor blockade: physiological and clinical implications |
| title_exact_search | Angiotensin II receptor blockade: physiological and clinical implications |
| title_full | Angiotensin II receptor blockade: physiological and clinical implications ed. by Naranjan S. Dhalla ... |
| title_fullStr | Angiotensin II receptor blockade: physiological and clinical implications ed. by Naranjan S. Dhalla ... |
| title_full_unstemmed | Angiotensin II receptor blockade: physiological and clinical implications ed. by Naranjan S. Dhalla ... |
| title_short | Angiotensin II receptor blockade: physiological and clinical implications |
| title_sort | angiotensin ii receptor blockade physiological and clinical implications |
| topic | Angiotensin II physiology Congresses Angiotensin converting enzyme Inhibitors Congresses Angiotensins Congresses Heart Diseases drug therapy Congresses Hypertension drug therapy Congresses Receptors, Angiotensin antagonists & inhibitors Congresses Renin-Angiotensin System physiology Congresses Pharmakologie (DE-588)4045687-0 gnd Angiotensin-II-Blocker (DE-588)4368837-8 gnd |
| topic_facet | Angiotensin II physiology Congresses Angiotensin converting enzyme Inhibitors Congresses Angiotensins Congresses Heart Diseases drug therapy Congresses Hypertension drug therapy Congresses Receptors, Angiotensin antagonists & inhibitors Congresses Renin-Angiotensin System physiology Congresses Pharmakologie Angiotensin-II-Blocker Konferenzschrift 1996 Winnipeg Manitoba |
| volume_link | (DE-604)BV012373475 |
| work_keys_str_mv | AT dhallanaranjans angiotensiniireceptorblockadephysiologicalandclinicalimplications |